Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Impax Laboratories Inc. v. Lannett Holdings Inc., No. 17-2020 (Fed. Cir. June 28, 2018)

Errata Correction sheet to a previously issued opinion
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 17-2020
Decided
June 28, 2018
Judge
Document
Errata
Length
1 page

United States Court of Appeals

for the Federal Circuit

July 2, 2018 ERRATUM

Appeal No. 2017-2020

IMPAX LABORATORIES INC., ASTRAZENECA AB,

ASTRAZENECA UK LIMITED,

Plaintiffs-Appellees

v.

LANNETT HOLDINGS INC., LANNETT COMPANY

INC.,

Defendants-Appellants Decided: June 28, 2018

Precedential Opinion

Please make the following change: On page 2, line 7, U.S. Patent 6,760,237 is changed to U.S. Patent 6,750,237.

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Impax Laboratories Inc. v. Lannett Holdings Inc., No. 17-2020 (Fed. Cir. June 28, 2018).

govinfo ID
USCOURTS-ca13-17-02020-1
Permalink
https://patentcasewatch.com/opinions/USCOURTS-ca13-17-02020-1

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.